GTHX Annual Revenue
$82.51 M
+$31.21 M+60.84%
31 December 2023
Summary:
As of January 27, 2025, GTHX annual revenue is $82.51 million, with the most recent change of +$31.21 million (+60.84%) on December 31, 2023. During the last 3 years, it has risen by +$37.23 million (+82.20%).GTHX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly Revenue
$16.55 M
+$2.07 M+14.30%
30 June 2024
Summary:
As of January 27, 2025, GTHX quarterly revenue is $16.55 million, with the most recent change of +$2.07 million (+14.30%) on June 30, 2024. Over the past year, it has dropped by -$25.85 million (-60.97%).GTHX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX TTM Revenue
$58.20 M
-$25.85 M-30.75%
30 June 2024
Summary:
As of January 27, 2025, GTHX TTM revenue is $58.20 million, with the most recent change of -$25.85 million (-30.75%) on June 30, 2024. Over the past year, it has dropped by -$30.97 million (-34.73%).GTHX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +60.8% | -61.0% | -34.7% |
3 y3 years | +82.2% | -61.0% | -34.7% |
5 y5 years | - | - | +2619.4% |
GTHX Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | at high | -61.0% | -34.7% |
G1 Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $16.55 M(+14.3%) | $58.20 M(-30.8%) |
Mar 2024 | - | $14.48 M(-2.7%) | $84.04 M(+1.9%) |
Dec 2023 | $82.51 M(+60.8%) | $14.87 M(+20.9%) | $82.51 M(+5.9%) |
Sept 2023 | - | $12.30 M(-71.0%) | $77.89 M(-12.6%) |
June 2023 | - | $42.39 M(+227.5%) | $89.16 M(+55.5%) |
Mar 2023 | - | $12.95 M(+26.3%) | $57.34 M(+11.8%) |
Dec 2022 | $51.30 M | $10.25 M(-56.5%) | $51.30 M(+9.5%) |
Sept 2022 | - | $23.58 M(+123.0%) | $46.85 M(+66.5%) |
June 2022 | - | $10.57 M(+53.2%) | $28.13 M(+16.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $6.90 M(+19.1%) | $24.16 M(-23.2%) |
Dec 2021 | $31.48 M(-30.5%) | $5.80 M(+19.3%) | $31.48 M(-25.5%) |
Sept 2021 | - | $4.86 M(-26.4%) | $42.23 M(-34.0%) |
June 2021 | - | $6.60 M(-53.6%) | $63.97 M(+7.5%) |
Mar 2021 | - | $14.22 M(-14.1%) | $59.50 M(+31.4%) |
Dec 2020 | $45.28 M(+8575.3%) | $16.55 M(-37.8%) | $45.28 M(+57.6%) |
Sept 2020 | - | $26.60 M(+1142.9%) | $28.74 M(+1242.9%) |
June 2020 | - | $2.14 M | $2.14 M |
Dec 2015 | $522.00 K | - | - |
FAQ
- What is G1 Therapeutics annual revenue?
- What is the all time high annual revenue for G1 Therapeutics?
- What is G1 Therapeutics annual revenue year-on-year change?
- What is G1 Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for G1 Therapeutics?
- What is G1 Therapeutics quarterly revenue year-on-year change?
- What is G1 Therapeutics TTM revenue?
- What is the all time high TTM revenue for G1 Therapeutics?
- What is G1 Therapeutics TTM revenue year-on-year change?
What is G1 Therapeutics annual revenue?
The current annual revenue of GTHX is $82.51 M
What is the all time high annual revenue for G1 Therapeutics?
G1 Therapeutics all-time high annual revenue is $82.51 M
What is G1 Therapeutics annual revenue year-on-year change?
Over the past year, GTHX annual revenue has changed by +$31.21 M (+60.84%)
What is G1 Therapeutics quarterly revenue?
The current quarterly revenue of GTHX is $16.55 M
What is the all time high quarterly revenue for G1 Therapeutics?
G1 Therapeutics all-time high quarterly revenue is $42.39 M
What is G1 Therapeutics quarterly revenue year-on-year change?
Over the past year, GTHX quarterly revenue has changed by -$25.85 M (-60.97%)
What is G1 Therapeutics TTM revenue?
The current TTM revenue of GTHX is $58.20 M
What is the all time high TTM revenue for G1 Therapeutics?
G1 Therapeutics all-time high TTM revenue is $89.16 M
What is G1 Therapeutics TTM revenue year-on-year change?
Over the past year, GTHX TTM revenue has changed by -$30.97 M (-34.73%)